Symposia programme
FRIDAY, 16 JUNE 2023
08.00h - 09.00h Breakfast Satellite Symposium. The role of PCPs in the early diagnosis and treatment of CKD in T2D
Meeting room: MR 05+06
Agenda:
- CKD in T2D – Treatment approaches and unmet needs - Ana Cebrian
- Finerenone in the current CKD in T2D therapeutic landscape - Samy Hadjaj
- Practical considerations for the management of patients with CKD and T2D - Boris Klanger
- Discussion panel: The significance of PCPs in early diagnosis for the treatment pathway
Sponsored by 
13.00 - 14.30h Lunch Satellite Symposium. Beyond Current Treatment Standards in Diabetes Care - The Central Role of Weight Loss
Meeting room: MR 05+06
Agenda:
- Introduction and Welcome - Melanie Davies
- Type 2 Diabetes Management in Primary Care - The Gap Between Guidelines and Clinical Practice - Stefan Jansson
- The Central Role of Weight Loss in Diabetes Care – Incretins on the Increase - Melanie Davies
- Delivering Contemporary Diabetes Care – A Practical Approach - Samuel Seidu
- Beyond Current Treatment Standards – A Mandate for Primary Care - Melanie Davies
- Q&A - All faculty
Organised by Medscape Education Global
17.30 - 19.00h Afternoon Satellite Symposium. Multi-organ impact: Harnessing the benefits of SGLT2 inhibitors
Chair: Pinar Topsever
Presenters: Ana Cebrian and Waqas Tahir
Agenda:
- Welcome and introduction - Pinar Topsever
- Where is your CKD patient? - Pinar Topsever
- SGLT2 inhibitors: Multi-organ protection for the primary care patient - Waqas Tahir
- Practical considerations for CKD management: Time to think differently - Ana Cebrian
- Panel discussion and Q&A - All faculty
- Summary and close - Pinar Topsever
Supported by an Unrestricted Educational Grant from AstraZeneca
SATURDAY, 17 JUNE 2023
08.00h - 09.15h Breakfast Satellite Symposium. Treatment of chronic kidney disease: new directions for daily clinical practice
Meeting room: MR 05+06
Chairs: Naresh Kanumilli (Manchester, UK) & Pinar Topsever (Istanbul, Turkey)
Agenda:
- Welcome & Introduction - Naresh Kanumilli (Manchester, UK)
- Increasing the utilization of diagnostic strategies in CKD - F. Javier Ampudia-Blasco (Valencia, Spain)
- Shaping the treatment of CKD with new approaches - Per-Henrik Groop (Helsinki, Finland)
- Strengthening successful CKD management in primary care - Naresh Kanumilli (Manchester, UK)
- Discussion & Closure - Pinar Topsever (Istanbul, Turkey)
Organized by Sciarc, kindly supported by a Medical Education Grant from Boehringer Ingelheim and Eli Lilly Alliance